Humana reported FY 2025 net income of USD 1.20 billion and diluted EPS of USD 9.84. Income from operations was USD 2.70 billion. Total revenues were USD 129.66 billion (+10.1%), including insurance premiums of USD 122.83 billion (+9.6%), services revenue of USD 5.83 billion (+31.6%), and investment income of USD 1.01 billion (-17.9%). Benefits expense was USD 110.81 billion (+10.1%), with a benefit ratio of 90.2 (up 0.4), while operating costs were USD 15.45 billion (+12.8%) and the operating cost ratio was 12.0 (up 0.2). Segment results showed Insurance income from operations of USD 1.66 billion (+29.1%) on external revenues of USD 123.84 billion (+9.5%), with a benefit ratio of 90.4 (unchanged). CenterWell income from operations was USD 1.34 billion, with total revenues of USD 22.47 billion (+12.7%) and external services revenue of USD 4.82 billion (+39.0%). Key updates included completion of Humana’s exit from its Employer Group Commercial Medical Products business during 2025, and continued value creation and transformation initiatives, with related charges of USD 449 million in FY 2025. The company also recorded impairment charges of USD 253 million and a loss on sale of business of USD 67 million. Humana ended FY 2025 with cash and cash equivalents of USD 4.20 billion (up from USD 2.20 billion). Insurance membership highlights included individual Medicare Advantage members of 5.25 million (down 7.3%), Medicare stand-alone PDP members of 2.46 million (+7.6%), and state-based contracts and other members of 1.62 million (+10.7%).

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Humana Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000049071-26-000009), on February 19, 2026, and is solely responsible for the information contained therein.